Compare NetEase Inc (NTES) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs State Street SPDR S&P Biotech ETF — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: NetEase Inc pays a 2.25% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, NetEase Inc nearer its low. Which is the better fit depends on your goals.
| NTES | XBI | |
|---|---|---|
Market Cap | $86.14B | — |
Sector | Media | Broad Market / Factor |
52-Week High | $159.34 | $164.28 |
52-Week Low | $109.26 | $85.16 |
Enterprise Value | $62.61B | — |
Dividend Yield | 2.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
